N-(4-chloro-1,3-benzothiazol-2-yl)-N-[2-(1H-pyrazol-1-yl)ethyl]cyclopropanecarboxamide structure
|
Common Name | N-(4-chloro-1,3-benzothiazol-2-yl)-N-[2-(1H-pyrazol-1-yl)ethyl]cyclopropanecarboxamide | ||
|---|---|---|---|---|
| CAS Number | 1169961-53-8 | Molecular Weight | 346.8 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H15ClN4OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-(4-chloro-1,3-benzothiazol-2-yl)-N-[2-(1H-pyrazol-1-yl)ethyl]cyclopropanecarboxamide |
|---|
| Molecular Formula | C16H15ClN4OS |
|---|---|
| Molecular Weight | 346.8 |
| InChIKey | DOJRAVXNVOBKIN-UHFFFAOYSA-N |
| SMILES | O=C(C1CC1)N(CCn1cccn1)c1nc2c(Cl)cccc2s1 |
|
Name: Screen for inhibitors of RMI FANCM (MM2) intereaction
Source: 11908
Target: N/A
External Id: RMI-FANCM-MM2
|
|
Name: Alphascreen assay for small molecules abrogating mHTT-CaM Interaction
Source: 24983
Target: Huntingtin
External Id: KUHTS-Muma KU-CaM-Htt INH-01
|